nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—PPARG—thyroid cancer	0.719	1	CbGaD
Repaglinide—ALB—Vandetanib—thyroid cancer	0.081	0.48	CbGbCtD
Repaglinide—CYP2C8—Sorafenib—thyroid cancer	0.0377	0.224	CbGbCtD
Repaglinide—CYP3A4—Vandetanib—thyroid cancer	0.0254	0.15	CbGbCtD
Repaglinide—CYP3A4—Sorafenib—thyroid cancer	0.0153	0.0907	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—thyroid cancer	0.00928	0.055	CbGbCtD
Repaglinide—Ischaemia—Sorafenib—thyroid cancer	0.00437	0.0486	CcSEcCtD
Repaglinide—Myocardial ischaemia—Sorafenib—thyroid cancer	0.00198	0.0221	CcSEcCtD
Repaglinide—Hypoglycaemia—Vandetanib—thyroid cancer	0.00176	0.0196	CcSEcCtD
Repaglinide—Pancreatitis—Vandetanib—thyroid cancer	0.00145	0.0162	CcSEcCtD
Repaglinide—Bronchitis—Vandetanib—thyroid cancer	0.00142	0.0159	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.0014	0.0624	CbGpPWpGaD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00134	0.0599	CbGpPWpGaD
Repaglinide—Hyperglycaemia—Vandetanib—thyroid cancer	0.00134	0.0149	CcSEcCtD
Repaglinide—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00132	0.0147	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00131	0.0146	CcSEcCtD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0013	0.0581	CbGpPWpGaD
Repaglinide—Urinary tract infection—Vandetanib—thyroid cancer	0.00128	0.0143	CcSEcCtD
Repaglinide—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00128	0.0142	CcSEcCtD
Repaglinide—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00125	0.0139	CcSEcCtD
Repaglinide—Sinusitis—Vandetanib—thyroid cancer	0.00124	0.0138	CcSEcCtD
Repaglinide—Visual impairment—Vandetanib—thyroid cancer	0.00114	0.0127	CcSEcCtD
Repaglinide—Erythema multiforme—Vandetanib—thyroid cancer	0.00112	0.0125	CcSEcCtD
Repaglinide—Eye disorder—Vandetanib—thyroid cancer	0.00111	0.0123	CcSEcCtD
Repaglinide—Cardiac disorder—Vandetanib—thyroid cancer	0.0011	0.0123	CcSEcCtD
Repaglinide—Arrhythmia—Vandetanib—thyroid cancer	0.00106	0.0118	CcSEcCtD
Repaglinide—Alopecia—Vandetanib—thyroid cancer	0.00105	0.0117	CcSEcCtD
Repaglinide—Malnutrition—Vandetanib—thyroid cancer	0.00103	0.0115	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—THRB—thyroid cancer	0.00103	0.0461	CbGpPWpGaD
Repaglinide—Pancreatitis—Sorafenib—thyroid cancer	0.00098	0.0109	CcSEcCtD
Repaglinide—Hypertension—Vandetanib—thyroid cancer	0.000891	0.00993	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.000883	0.00984	CcSEcCtD
Repaglinide—Arthralgia—Vandetanib—thyroid cancer	0.000879	0.00979	CcSEcCtD
Repaglinide—Chest pain—Vandetanib—thyroid cancer	0.000879	0.00979	CcSEcCtD
Repaglinide—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000878	0.00979	CcSEcCtD
Repaglinide—Myocardial infarction—Sorafenib—thyroid cancer	0.000873	0.00973	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000873	0.00972	CcSEcCtD
Repaglinide—Jaundice—Sorafenib—thyroid cancer	0.000869	0.00968	CcSEcCtD
Repaglinide—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000843	0.00939	CcSEcCtD
Repaglinide—Oedema—Vandetanib—thyroid cancer	0.000842	0.00939	CcSEcCtD
Repaglinide—Thrombocytopenia—Vandetanib—thyroid cancer	0.000825	0.00919	CcSEcCtD
Repaglinide—Skin disorder—Vandetanib—thyroid cancer	0.000818	0.00912	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.000816	0.0364	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000768	0.00855	CcSEcCtD
Repaglinide—Paraesthesia—Vandetanib—thyroid cancer	0.000757	0.00843	CcSEcCtD
Repaglinide—Erythema multiforme—Sorafenib—thyroid cancer	0.000756	0.00843	CcSEcCtD
Repaglinide—Cardiac disorder—Sorafenib—thyroid cancer	0.000742	0.00827	CcSEcCtD
Repaglinide—Dyspepsia—Vandetanib—thyroid cancer	0.000742	0.00826	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000727	0.0081	CcSEcCtD
Repaglinide—Immune system disorder—Sorafenib—thyroid cancer	0.000723	0.00805	CcSEcCtD
Repaglinide—Constipation—Vandetanib—thyroid cancer	0.00072	0.00803	CcSEcCtD
Repaglinide—Arrhythmia—Sorafenib—thyroid cancer	0.000715	0.00796	CcSEcCtD
Repaglinide—Alopecia—Sorafenib—thyroid cancer	0.000707	0.00787	CcSEcCtD
Repaglinide—Malnutrition—Sorafenib—thyroid cancer	0.000696	0.00776	CcSEcCtD
Repaglinide—Erythema—Sorafenib—thyroid cancer	0.000696	0.00776	CcSEcCtD
Repaglinide—SLCO1B1—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00069	0.0308	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000689	0.00767	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.000679	0.0303	CbGpPWpGaD
Repaglinide—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00067	0.00746	CcSEcCtD
Repaglinide—Abdominal pain—Vandetanib—thyroid cancer	0.000666	0.00742	CcSEcCtD
Repaglinide—Leukopenia—Sorafenib—thyroid cancer	0.000623	0.00694	CcSEcCtD
Repaglinide—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00062	0.00691	CcSEcCtD
Repaglinide—Hypertension—Sorafenib—thyroid cancer	0.000601	0.0067	CcSEcCtD
Repaglinide—Pruritus—Vandetanib—thyroid cancer	0.000596	0.00664	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.000594	0.0265	CbGpPWpGaD
Repaglinide—Arthralgia—Sorafenib—thyroid cancer	0.000593	0.0066	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000589	0.00656	CcSEcCtD
Repaglinide—Diarrhoea—Vandetanib—thyroid cancer	0.000576	0.00642	CcSEcCtD
Repaglinide—Anaphylactic shock—Sorafenib—thyroid cancer	0.000568	0.00633	CcSEcCtD
Repaglinide—Thrombocytopenia—Sorafenib—thyroid cancer	0.000556	0.0062	CcSEcCtD
Repaglinide—Skin disorder—Sorafenib—thyroid cancer	0.000552	0.00615	CcSEcCtD
Repaglinide—ABCC8—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.000544	0.0243	CbGpPWpGaD
Repaglinide—Vomiting—Vandetanib—thyroid cancer	0.000536	0.00597	CcSEcCtD
Repaglinide—Rash—Vandetanib—thyroid cancer	0.000531	0.00592	CcSEcCtD
Repaglinide—Dermatitis—Vandetanib—thyroid cancer	0.000531	0.00591	CcSEcCtD
Repaglinide—Headache—Vandetanib—thyroid cancer	0.000528	0.00588	CcSEcCtD
Repaglinide—KCNJ11—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.000528	0.0235	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000518	0.00577	CcSEcCtD
Repaglinide—Nausea—Vandetanib—thyroid cancer	0.0005	0.00557	CcSEcCtD
Repaglinide—Dyspepsia—Sorafenib—thyroid cancer	0.0005	0.00557	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000491	0.00547	CcSEcCtD
Repaglinide—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000489	0.00545	CcSEcCtD
Repaglinide—Constipation—Sorafenib—thyroid cancer	0.000486	0.00541	CcSEcCtD
Repaglinide—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000471	0.00525	CcSEcCtD
Repaglinide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000465	0.00518	CcSEcCtD
Repaglinide—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000452	0.00504	CcSEcCtD
Repaglinide—Urticaria—Sorafenib—thyroid cancer	0.000451	0.00503	CcSEcCtD
Repaglinide—Abdominal pain—Sorafenib—thyroid cancer	0.000449	0.005	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000442	0.00492	CcSEcCtD
Repaglinide—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000441	0.0197	CbGpPWpGaD
Repaglinide—PPARG—Nuclear Receptors—RXRA—thyroid cancer	0.000439	0.0196	CbGpPWpGaD
Repaglinide—Hypoglycaemia—Epirubicin—thyroid cancer	0.000438	0.00488	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000436	0.00486	CcSEcCtD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.000433	0.0193	CbGpPWpGaD
Repaglinide—ABCC8—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000428	0.0191	CbGpPWpGaD
Repaglinide—Hypersensitivity—Sorafenib—thyroid cancer	0.000419	0.00466	CcSEcCtD
Repaglinide—KCNJ11—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000415	0.0185	CbGpPWpGaD
Repaglinide—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000409	0.00455	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000405	0.00451	CcSEcCtD
Repaglinide—Pruritus—Sorafenib—thyroid cancer	0.000402	0.00448	CcSEcCtD
Repaglinide—ALB—Recycling of bile acids and salts—RXRA—thyroid cancer	0.000394	0.0176	CbGpPWpGaD
Repaglinide—Diarrhoea—Sorafenib—thyroid cancer	0.000389	0.00433	CcSEcCtD
Repaglinide—Pancreatitis—Epirubicin—thyroid cancer	0.000362	0.00403	CcSEcCtD
Repaglinide—Vomiting—Sorafenib—thyroid cancer	0.000361	0.00403	CcSEcCtD
Repaglinide—SLCO1B1—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000361	0.0161	CbGpPWpGaD
Repaglinide—Angina pectoris—Epirubicin—thyroid cancer	0.00036	0.00401	CcSEcCtD
Repaglinide—Rash—Sorafenib—thyroid cancer	0.000358	0.00399	CcSEcCtD
Repaglinide—Dermatitis—Sorafenib—thyroid cancer	0.000358	0.00399	CcSEcCtD
Repaglinide—Headache—Sorafenib—thyroid cancer	0.000356	0.00397	CcSEcCtD
Repaglinide—Bronchitis—Epirubicin—thyroid cancer	0.000355	0.00396	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000347	0.0155	CbGpPWpGaD
Repaglinide—Nausea—Sorafenib—thyroid cancer	0.000338	0.00376	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—thyroid cancer	0.000335	0.00373	CcSEcCtD
Repaglinide—Hyperglycaemia—Epirubicin—thyroid cancer	0.000333	0.00371	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—thyroid cancer	0.000333	0.00371	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—thyroid cancer	0.000329	0.00366	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000326	0.00364	CcSEcCtD
Repaglinide—Jaundice—Epirubicin—thyroid cancer	0.000321	0.00358	CcSEcCtD
Repaglinide—Urinary tract infection—Epirubicin—thyroid cancer	0.00032	0.00357	CcSEcCtD
Repaglinide—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000311	0.00347	CcSEcCtD
Repaglinide—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00031	0.0138	CbGpPWpGaD
Repaglinide—Sinusitis—Epirubicin—thyroid cancer	0.000309	0.00344	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000308	0.00343	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000302	0.00337	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—thyroid cancer	0.000297	0.00331	CcSEcCtD
Repaglinide—Rhinitis—Epirubicin—thyroid cancer	0.000296	0.0033	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—thyroid cancer	0.000296	0.0033	CcSEcCtD
Repaglinide—Hepatitis—Epirubicin—thyroid cancer	0.000296	0.00329	CcSEcCtD
Repaglinide—Oedema peripheral—Epirubicin—thyroid cancer	0.000291	0.00324	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000288	0.00321	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—thyroid cancer	0.000286	0.00318	CcSEcCtD
Repaglinide—PPARG—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000285	0.0127	CbGpPWpGaD
Repaglinide—Visual impairment—Epirubicin—thyroid cancer	0.000285	0.00317	CcSEcCtD
Repaglinide—Erythema multiforme—Epirubicin—thyroid cancer	0.00028	0.00311	CcSEcCtD
Repaglinide—Eye disorder—Epirubicin—thyroid cancer	0.000276	0.00308	CcSEcCtD
Repaglinide—Cardiac disorder—Epirubicin—thyroid cancer	0.000274	0.00306	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—thyroid cancer	0.000274	0.00306	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—thyroid cancer	0.000274	0.00305	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—thyroid cancer	0.000269	0.003	CcSEcCtD
Repaglinide—Immune system disorder—Epirubicin—thyroid cancer	0.000267	0.00297	CcSEcCtD
Repaglinide—Arrhythmia—Epirubicin—thyroid cancer	0.000264	0.00294	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—thyroid cancer	0.000264	0.00294	CcSEcCtD
Repaglinide—Alopecia—Epirubicin—thyroid cancer	0.000261	0.00291	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—thyroid cancer	0.000259	0.00288	CcSEcCtD
Repaglinide—Malnutrition—Epirubicin—thyroid cancer	0.000257	0.00287	CcSEcCtD
Repaglinide—Erythema—Epirubicin—thyroid cancer	0.000257	0.00287	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—thyroid cancer	0.000256	0.00285	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—thyroid cancer	0.000254	0.00283	CcSEcCtD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—RXRA—thyroid cancer	0.000249	0.0111	CbGpPWpGaD
Repaglinide—Back pain—Epirubicin—thyroid cancer	0.000249	0.00277	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—thyroid cancer	0.000247	0.00275	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—thyroid cancer	0.000244	0.00272	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—thyroid cancer	0.000242	0.00269	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—thyroid cancer	0.000238	0.00265	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—thyroid cancer	0.000238	0.00265	CcSEcCtD
Repaglinide—Leukopenia—Epirubicin—thyroid cancer	0.00023	0.00257	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—thyroid cancer	0.00023	0.00257	CcSEcCtD
Repaglinide—Palpitations—Epirubicin—thyroid cancer	0.000227	0.00253	CcSEcCtD
Repaglinide—Hypertension—Epirubicin—thyroid cancer	0.000222	0.00248	CcSEcCtD
Repaglinide—Arthralgia—Epirubicin—thyroid cancer	0.000219	0.00244	CcSEcCtD
Repaglinide—Chest pain—Epirubicin—thyroid cancer	0.000219	0.00244	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000218	0.00242	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—thyroid cancer	0.000213	0.00237	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—thyroid cancer	0.00021	0.00234	CcSEcCtD
Repaglinide—Oedema—Epirubicin—thyroid cancer	0.00021	0.00234	CcSEcCtD
Repaglinide—Anaphylactic shock—Epirubicin—thyroid cancer	0.00021	0.00234	CcSEcCtD
Repaglinide—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000206	0.00919	CbGpPWpGaD
Repaglinide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000206	0.00229	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—thyroid cancer	0.000206	0.00229	CcSEcCtD
Repaglinide—Skin disorder—Epirubicin—thyroid cancer	0.000204	0.00227	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—thyroid cancer	0.000203	0.00226	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—thyroid cancer	0.000203	0.00226	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000201	0.00224	CcSEcCtD
Repaglinide—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000201	0.00896	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000195	0.00869	CbGpPWpGaD
Repaglinide—Oedema—Doxorubicin—thyroid cancer	0.000194	0.00216	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000194	0.00216	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000191	0.00213	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00019	0.00212	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—thyroid cancer	0.000189	0.0021	CcSEcCtD
Repaglinide—Paraesthesia—Epirubicin—thyroid cancer	0.000189	0.0021	CcSEcCtD
Repaglinide—PPARG—PPARA activates gene expression—RXRA—thyroid cancer	0.000187	0.00836	CbGpPWpGaD
Repaglinide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000185	0.00827	CbGpPWpGaD
Repaglinide—Dyspepsia—Epirubicin—thyroid cancer	0.000185	0.00206	CcSEcCtD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000183	0.00818	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000181	0.00202	CcSEcCtD
Repaglinide—Constipation—Epirubicin—thyroid cancer	0.00018	0.002	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000177	0.00197	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—thyroid cancer	0.000175	0.0078	CbGpPWpGaD
Repaglinide—Paraesthesia—Doxorubicin—thyroid cancer	0.000175	0.00194	CcSEcCtD
Repaglinide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000172	0.00191	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—thyroid cancer	0.000171	0.00191	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000168	0.00187	CcSEcCtD
Repaglinide—Urticaria—Epirubicin—thyroid cancer	0.000167	0.00186	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—thyroid cancer	0.000166	0.00185	CcSEcCtD
Repaglinide—Abdominal pain—Epirubicin—thyroid cancer	0.000166	0.00185	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—RXRA—thyroid cancer	0.000164	0.00731	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000159	0.00177	CcSEcCtD
Repaglinide—Hypersensitivity—Epirubicin—thyroid cancer	0.000155	0.00172	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—thyroid cancer	0.000154	0.00172	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—thyroid cancer	0.000154	0.00171	CcSEcCtD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—CCND1—thyroid cancer	0.000153	0.00683	CbGpPWpGaD
Repaglinide—Pruritus—Epirubicin—thyroid cancer	0.000149	0.00166	CcSEcCtD
Repaglinide—Diarrhoea—Epirubicin—thyroid cancer	0.000144	0.0016	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000143	0.0016	CcSEcCtD
Repaglinide—PPARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000141	0.00629	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000139	0.00621	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000138	0.00614	CbGpPWpGaD
Repaglinide—Pruritus—Doxorubicin—thyroid cancer	0.000137	0.00153	CcSEcCtD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000136	0.00606	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—MINPP1—thyroid cancer	0.000134	0.00599	CbGpPWpGaD
Repaglinide—Vomiting—Epirubicin—thyroid cancer	0.000134	0.00149	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—thyroid cancer	0.000133	0.00148	CcSEcCtD
Repaglinide—Rash—Epirubicin—thyroid cancer	0.000132	0.00148	CcSEcCtD
Repaglinide—Dermatitis—Epirubicin—thyroid cancer	0.000132	0.00147	CcSEcCtD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000132	0.00588	CbGpPWpGaD
Repaglinide—Headache—Epirubicin—thyroid cancer	0.000132	0.00147	CcSEcCtD
Repaglinide—KCNJ11—Metabolism—MINPP1—thyroid cancer	0.00013	0.00581	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.000127	0.00565	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000126	0.00564	CbGpPWpGaD
Repaglinide—Nausea—Epirubicin—thyroid cancer	0.000125	0.00139	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—thyroid cancer	0.000124	0.00138	CcSEcCtD
Repaglinide—Rash—Doxorubicin—thyroid cancer	0.000123	0.00137	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—thyroid cancer	0.000122	0.00136	CcSEcCtD
Repaglinide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000122	0.00545	CbGpPWpGaD
Repaglinide—Headache—Doxorubicin—thyroid cancer	0.000122	0.00136	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—HIF1A—thyroid cancer	0.000122	0.00543	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000118	0.00526	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000118	0.00526	CbGpPWpGaD
Repaglinide—Nausea—Doxorubicin—thyroid cancer	0.000115	0.00129	CcSEcCtD
Repaglinide—ABCC8—Metabolism—NDUFA13—thyroid cancer	0.000114	0.0051	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000112	0.00498	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NDUFA13—thyroid cancer	0.000111	0.00494	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00011	0.00489	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000108	0.00481	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CHST14—thyroid cancer	0.000107	0.00479	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000106	0.00474	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000106	0.00474	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000104	0.00466	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CHST14—thyroid cancer	0.000104	0.00465	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MINPP1—thyroid cancer	9.63e-05	0.0043	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—TRIM33—thyroid cancer	9.38e-05	0.00419	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MEN1—thyroid cancer	8.95e-05	0.00399	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	8.82e-05	0.00394	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—HPGD—thyroid cancer	8.66e-05	0.00386	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—thyroid cancer	8.52e-05	0.0038	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—HPGD—thyroid cancer	8.39e-05	0.00374	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NDUFA13—thyroid cancer	8.19e-05	0.00365	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.95e-05	0.00355	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.91e-05	0.00353	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CHST14—thyroid cancer	7.7e-05	0.00343	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—BRAF—thyroid cancer	7.64e-05	0.00341	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MINPP1—thyroid cancer	7.58e-05	0.00338	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—BRAF—thyroid cancer	7.4e-05	0.0033	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.39e-05	0.0033	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	7.35e-05	0.00328	CbGpPWpGaD
Repaglinide—PPARG—SREBP signalling—AKT1—thyroid cancer	6.79e-05	0.00303	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—THRB—thyroid cancer	6.78e-05	0.00303	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	6.74e-05	0.003	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	6.74e-05	0.003	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.68e-05	0.00298	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	6.45e-05	0.00288	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.3e-05	0.00281	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.27e-05	0.0028	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HPGD—thyroid cancer	6.2e-05	0.00277	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CDK1—thyroid cancer	6.07e-05	0.00271	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CHST14—thyroid cancer	6.06e-05	0.0027	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.99e-05	0.00267	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	5.99e-05	0.00267	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.99e-05	0.00267	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—RXRA—thyroid cancer	5.99e-05	0.00267	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—RXRA—thyroid cancer	5.93e-05	0.00265	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.89e-05	0.00263	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RXRA—thyroid cancer	5.63e-05	0.00251	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	5.04e-05	0.00225	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.03e-05	0.00224	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—PTEN—thyroid cancer	5.01e-05	0.00224	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	5.01e-05	0.00223	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TPR—thyroid cancer	4.97e-05	0.00222	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PRKAR1A—thyroid cancer	4.89e-05	0.00218	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HPGD—thyroid cancer	4.88e-05	0.00218	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TPR—thyroid cancer	4.82e-05	0.00215	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PRKAR1A—thyroid cancer	4.74e-05	0.00212	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—TPR—thyroid cancer	4.58e-05	0.00204	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.48e-05	0.002	CbGpPWpGaD
Repaglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	4.38e-05	0.00195	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MINPP1—thyroid cancer	4.36e-05	0.00194	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MINPP1—thyroid cancer	4.33e-05	0.00193	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MEN1—thyroid cancer	4.31e-05	0.00192	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.96e-05	0.00177	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PRKAR1A—thyroid cancer	3.89e-05	0.00174	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.77e-05	0.00168	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—thyroid cancer	3.75e-05	0.00167	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SLC5A5—thyroid cancer	3.72e-05	0.00166	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.7e-05	0.00165	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NDUFA13—thyroid cancer	3.68e-05	0.00164	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SLC5A5—thyroid cancer	3.61e-05	0.00161	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TPR—thyroid cancer	3.56e-05	0.00159	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—HRAS—thyroid cancer	3.51e-05	0.00157	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PRKAR1A—thyroid cancer	3.51e-05	0.00156	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CHST14—thyroid cancer	3.48e-05	0.00155	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CHST14—thyroid cancer	3.46e-05	0.00154	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	3.42e-05	0.00153	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	3.42e-05	0.00153	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—thyroid cancer	3.42e-05	0.00153	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—HRAS—thyroid cancer	3.4e-05	0.00152	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.37e-05	0.0015	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.18e-05	0.00142	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—RXRA—thyroid cancer	3.13e-05	0.0014	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—RXRA—thyroid cancer	3.03e-05	0.00135	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—RXRA—thyroid cancer	2.88e-05	0.00129	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HPGD—thyroid cancer	2.81e-05	0.00125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TPR—thyroid cancer	2.81e-05	0.00125	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HPGD—thyroid cancer	2.79e-05	0.00125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	2.76e-05	0.00123	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC5A5—thyroid cancer	2.67e-05	0.00119	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA2—thyroid cancer	2.58e-05	0.00115	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.56e-05	0.00114	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.5e-05	0.00112	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.5e-05	0.00112	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.34e-05	0.00104	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.28e-05	0.00102	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.26e-05	0.00101	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—RXRA—thyroid cancer	2.24e-05	0.001	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.18e-05	0.000972	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NRAS—thyroid cancer	2.18e-05	0.000971	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.15e-05	0.00096	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.1e-05	0.000937	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.99e-05	0.000887	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPARG—thyroid cancer	1.97e-05	0.000881	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.97e-05	0.000878	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPARG—thyroid cancer	1.91e-05	0.000854	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—thyroid cancer	1.87e-05	0.000836	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CHST14—thyroid cancer	1.87e-05	0.000834	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—RXRA—thyroid cancer	1.76e-05	0.000787	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.72e-05	0.000766	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TPR—thyroid cancer	1.61e-05	0.000719	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TPR—thyroid cancer	1.6e-05	0.000715	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—thyroid cancer	1.59e-05	0.000711	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.59e-05	0.000708	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PRKAR1A—thyroid cancer	1.58e-05	0.000704	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—thyroid cancer	1.55e-05	0.000693	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HPGD—thyroid cancer	1.51e-05	0.000672	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—thyroid cancer	1.51e-05	0.000672	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.44e-05	0.000641	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.43e-05	0.000638	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—thyroid cancer	1.41e-05	0.000628	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—thyroid cancer	1.35e-05	0.000604	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—thyroid cancer	1.31e-05	0.000586	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000538	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.2e-05	0.000537	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.000535	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.13e-05	0.000505	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.12e-05	0.000502	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.11e-05	0.000497	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—thyroid cancer	1.11e-05	0.000497	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RXRA—thyroid cancer	1.01e-05	0.000452	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RXRA—thyroid cancer	1.01e-05	0.00045	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.86e-06	0.00044	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.81e-06	0.000438	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—thyroid cancer	9.71e-06	0.000433	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—thyroid cancer	9.61e-06	0.000429	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—thyroid cancer	8.76e-06	0.000391	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TPR—thyroid cancer	8.65e-06	0.000386	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.51e-06	0.00038	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—thyroid cancer	8.27e-06	0.000369	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—thyroid cancer	7.81e-06	0.000348	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—thyroid cancer	7.64e-06	0.000341	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—thyroid cancer	7.57e-06	0.000338	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—thyroid cancer	7.35e-06	0.000328	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—thyroid cancer	7.19e-06	0.000321	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—thyroid cancer	7.03e-06	0.000314	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.48e-06	0.000289	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—thyroid cancer	6.4e-06	0.000286	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—thyroid cancer	6.37e-06	0.000284	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—thyroid cancer	6.21e-06	0.000277	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—thyroid cancer	5.59e-06	0.00025	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RXRA—thyroid cancer	5.44e-06	0.000243	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—thyroid cancer	5.04e-06	0.000225	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—thyroid cancer	5.01e-06	0.000223	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—thyroid cancer	4.41e-06	0.000197	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—thyroid cancer	4.39e-06	0.000196	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—thyroid cancer	4.37e-06	0.000195	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—thyroid cancer	3.44e-06	0.000153	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.7e-06	0.000121	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—thyroid cancer	2.53e-06	0.000113	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—thyroid cancer	2.52e-06	0.000112	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—thyroid cancer	2.36e-06	0.000105	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—thyroid cancer	1.36e-06	6.06e-05	CbGpPWpGaD
